News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

News|Articles|July 1, 2015

Cell Therapies

Eric Langer, Managing partner at BioPlan Associates, speaks with Pharmaceutical Technology about emerging trends in cell therapy.

Eric Langer, Managing Partner at BioPlan Associates, spoke with Pharmaceutical Technology about emerging trends in cell therapy.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Related Content

Regulatory Developments Impacting Biologics

BySusan J. Schniepp,Siegfried Schmitt,Susan Haigney

June 30th 2026

Oxylanthanum carbonate was rejected for the 2nd time by the FDA

Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection

ByZachary Zubulake

June 30th 2026

Antibody drug conjugate in blue with four drug compounds linked to IgG immunoglobulin; ADC in blue against blue background 3d render | Image Credit: ©huenstructurebio.com -stock.adobe.com

Lonza Increases HPAPI Production at Visp Facility

BySusan Haigney

June 30th 2026

Pill with American flag wrapped around it and red ball inside | Image Credit: ©fabioberti.it -stock.adobe.com

FDA Chooses 7 Companies for PreCheck Pilot

BySusan Haigney

June 30th 2026

Quality Assurance

Documentation Reliability Across Contractors: A Quality Systems Approach

ByPawankumar Suresh, MS, CSM

June 30th 2026

Trending on Pharmaceutical Technology

PharmTech Weekly Roundup—June 26, 2026

Drug Digest: How Advanced Analytics Partnerships Enhance the Biopharma Value Chain

FDA Chooses 7 Companies for PreCheck Pilot

Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value

PharmTech Explained: Human Accountability with AI in GMP